Nika Pharmaceuticals, Inc SEC filings NIKA
Nika Pharmaceuticals, Inc has 71 filings in SEC EDGAR's recent list, going back to Dec 3, 2020. Its latest annual report, Form 10-K, was filed on Mar 25, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2024 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Oct 8, 2024 | — |
| RW | Form rw | Sep 19, 2024 | — |
| RW | Form-rw | Sep 16, 2024 | — |
| RW | Filing | Sep 12, 2024 | — |
| NT 10-Q | From 12b-25 | Aug 14, 2024 | Jun 30, 2024 |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| NT 10-Q | Form 12b-25 | May 16, 2024 | Mar 31, 2024 |
| CORRESP | Letter to the SEC | May 9, 2024 | — |
| UPLOAD | Letter from the SEC | May 2, 2024 | — |
| DEL AM | Form del am | Mar 8, 2024 | — |
| NT 10-Q | Form nt 10-q | Aug 14, 2023 | Jun 30, 2023 |
| NT 10-K | Form nt 10-k | Mar 31, 2023 | Dec 31, 2022 |
| NT 10-Q | Form nt 10-q | Aug 15, 2022 | Jun 30, 2022 |
| UPLOAD | Letter from the SEC | Jan 22, 2021 | — |
| 10-12G/A | Form 10-12g/a | Jan 21, 2021 | — |
| 10-12G/A | Form 10-12g/a | Jan 21, 2021 | — |
| CORRESP | Letter to the SEC | Jan 20, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2021 | — |
| RW | Filing | Dec 30, 2020 | — |
| RW WD | Filing | Dec 29, 2020 | — |
| RW | Filing | Dec 29, 2020 | — |
| 10-12G | Form 10-12g | Dec 28, 2020 | — |
| 1-A-W | Form aw | Dec 23, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| 10-12B | Form 10-12b | Dec 3, 2020 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NIKA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- CO
- Headquarters
- Henderson, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1145604
- Former names
- CENTENNIAL GROWTH EQUITIES INC (until Aug 15, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.